Medium-dose UVA1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cells
Authors:
Open Access
- 1 November 2001
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 45 (5) , 697-699
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- PUVA-cream photochemotherapy for the treatment of localized sclerodermaJournal of the American Academy of Dermatology, 2000
- Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosisJournal of the American Academy of Dermatology, 2000
- Low-dose UVA1 phototherapy for treatment of localized sclerodermaJournal of the American Academy of Dermatology, 1998
- Induction of interstitial collagenase (MMP-1) by UVA-1 phototherapy in morphea fibroblastsThe Lancet, 1997
- Psoralen UVA therapy for linear and generalized morpheaJournal of the American Academy of Dermatology, 1997
- Decreased Expression of the Human Progenitor Cell Antigen (CD34) in MorpheaThe American Journal of Dermatopathology, 1995
- Decreased Collagenase Expression in Cultured Systemic Sclerosis FibroblastsJournal of Investigative Dermatology, 1994
- CD34+ Spindle-Shaped Cells Selectively Disappear From the Skin Lesion of SclerodermaArchives of Dermatology, 1994
- Ultraviolet A Irradiation Stimulates Collagenase Production in Cultured Human FibroblastsJournal of Investigative Dermatology, 1992
- UVA-induced tumours in pigmented hairless mice and the carcinogenic risks of tanning with UVAArchives of Dermatological Research, 1990